Private equity major Apax Partners is said to be mulling over the sale of its Swiss diagnostic services company Unilabs.
The firm is currently working with Rothschild & Co on the potential sale, people with knowledge of the matter told Bloomberg.
Apax is believed to targeting around $4.4bn for Unilabs including debt, the people said.
The process is still at an early stage and Apax may choose to not to sell the business, they added.
Unilabs was founded in 1987 and provides a range of laboratory, imaging and pathology services across Europe.
The company operates more than 250 laboratories internationally and has achieved sales of over €1bn per annum, according to its website.
The Swiss diagnostics specialist was taken private by Apax Partners, Apax France and Nordic Capital in 2007 before being merged with the diagnostics division of European healthcare group Capio the following year.
Apax Partners later used its $9bn global investment fund, Apax IX, to buyout the other investors in 2017.
Last week, Apax bought litigation services provider Lexitas from fellow buyout house Trinity Hunt Partners.
Copyright © 2019 AltAssets